Stockscreener 앱 받기
14.74
3.22%
-0.49
시간 외 거래:
14.70
-0.04
-0.27%
전일 마감가:
$15.23
열려 있는:
$15.12
하루 거래량:
2.26M
Relative Volume:
1.09
시가총액:
$1.51B
수익:
-
순이익/손실:
$-804.34M
주가수익비율:
-1.5664
EPS:
-9.41
순현금흐름:
$-531.06M
1주 성능:
+0.20%
1개월 성능:
+5.74%
6개월 성능:
-61.64%
1년 성능:
-59.75%
1일 변동 폭
$14.02
$15.28
1주일 범위
$14.02
$15.29
52주 변동 폭
$12.79
$55.70
바이오헤이븐 Stock (BHVN) Company Profile
명칭
Biohaven Ltd
전화
203-404-0410
주소
215 CHURCH STREET, NEW HAVEN, CT
BHVN을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BHVN
Biohaven Ltd
|
14.74 | 1.54B | 0 | -804.34M | -531.06M | -9.41 |
|
VRTX
Vertex Pharmaceuticals Inc
|
366.54 | 98.88B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.00 | 58.84B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
438.93 | 56.12B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
661.83 | 41.20B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
288.18 | 35.49B | 3.81B | -644.79M | -669.77M | -6.24 |
바이오헤이븐 Stock (BHVN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-05-19 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2025-02-11 | 개시 | Deutsche Bank | Buy |
| 2024-09-16 | 개시 | Jefferies | Buy |
| 2024-09-04 | 개시 | Bernstein | Outperform |
| 2024-07-24 | 개시 | Morgan Stanley | Overweight |
| 2024-02-16 | 개시 | RBC Capital Mkts | Outperform |
| 2024-02-06 | 개시 | UBS | Buy |
| 2023-12-22 | 개시 | H.C. Wainwright | Buy |
| 2023-12-08 | 개시 | Robert W. Baird | Outperform |
| 2023-01-24 | 개시 | SVB Securities | Outperform |
| 2023-01-04 | 개시 | JP Morgan | Overweight |
| 2022-12-02 | 개시 | BTIG Research | Buy |
| 2022-10-26 | 업그레이드 | Cantor Fitzgerald | Neutral → Overweight |
| 2022-10-12 | 개시 | Piper Sandler | Overweight |
| 2022-08-19 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2022-08-08 | 다운그레이드 | Wedbush | Outperform → Neutral |
| 2022-05-11 | 다운그레이드 | SVB Leerink | Outperform → Mkt Perform |
| 2021-10-19 | 재개 | Morgan Stanley | Equal-Weight |
| 2021-08-10 | 다운그레이드 | UBS | Buy → Neutral |
| 2021-08-03 | 재확인 | Canaccord Genuity | Buy |
| 2021-03-11 | 개시 | UBS | Buy |
| 2020-12-15 | 개시 | H.C. Wainwright | Buy |
| 2020-04-17 | 개시 | Cowen | Outperform |
| 2020-02-10 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2020-02-06 | 개시 | Mizuho | Buy |
| 2019-11-22 | 개시 | Wedbush | Outperform |
| 2019-06-25 | 재확인 | Canaccord Genuity | Buy |
| 2019-05-06 | 개시 | Goldman | Buy |
| 2019-04-09 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2019-03-04 | 재확인 | Needham | Buy |
| 2018-07-03 | 재확인 | Needham | Buy |
| 2018-07-02 | 재확인 | Needham | Buy |
| 2018-04-05 | 다운그레이드 | Barclays | Overweight → Equal Weight |
| 2018-02-22 | 재확인 | Canaccord Genuity | Buy |
| 2017-12-15 | 개시 | Canaccord Genuity | Buy |
| 2017-10-03 | 재확인 | Needham | Buy |
모두보기
바이오헤이븐 주식(BHVN)의 최신 뉴스
BHVN Investors Have Opportunity to Lead Biohaven Ltd. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today! - ACCESS Newswire
Visual analytics tools that track Biohaven Ltd. performancePredictive Short-Term Market Reversal Alerts - Newser
Candlestick signals on Biohaven Ltd. stock todayAI Screener for Daily Stock Forecast - Newser
BHVN ALERT: Levi & Korsinsky Files Securities Fraud Class Action Against Biohaven Ltd.September 12, 2025 Deadline - ACCESS Newswire
Biohaven Ltd. stock prediction for this weekPrice Action Trading with Volume Confirmation - Newser
Published on: 2025-08-09 04:28:36 - Newser
Biohaven Ltd. (NYSE:BHVN) Receives Average Rating of “Buy” from Brokerages - Defense World
Can Biohaven Ltd. recover in the next quarterFree Earnings Play Trade Plan With Alerts - Newser
Applying big data sentiment scoring on Biohaven Ltd.Investment Timeline and ROI Summary Report - Newser
Real time alert setup for Biohaven Ltd. performanceFree Breakout Entry Signal Confirmation Tool - Newser
Class Action Filed Against Biohaven Ltd. (BHVN) Over Securities ViolationsContact Levi & Korsinsky Today - ACCESS Newswire
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Biohaven Ltd.(BHVN) Shareholders - GlobeNewswire
DEADLINE ALERT for HIMS, IRBT, CNC, BHVN: Law Offices of Howard G. Smith Reminds Investors of Opportunity to Lead Securities Fraud Class Actions - GlobeNewswire Inc.
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Biohaven - PR Newswire
Shareholders that lost money on Biohaven Ltd.(BHVN) Urged to Join Class ActionContact Levi & Korsinsky to Learn More - Morningstar
Exit strategy if you’re trapped in Biohaven Ltd.High Probability Trade Plan with Indicators - Newser
How to interpret RSI for Biohaven Ltd. stockFree Daily Volume Spike Trading Signals - Newser
Deadline Alert: Biohaven Ltd. (BHVN) Investors Who Lost - GlobeNewswire
BHVN LAWSUIT ALERT: Levi & Korsinsky Notifies Biohaven Ltd. InvestorsLead Plaintiff Deadline September 12, 2025 - ACCESS Newswire
Biohaven Ltd. Sued for Securities Law ViolationsContact The Gross Law Firm Before September 12, 2025 to Discuss Your RightsBHVN - Barchart.com
Biohaven (BHVN) to Release Quarterly Earnings on Thursday - Defense World
Biohaven Ltd. (NYSE:BHVN) Shares Bought by Zurcher Kantonalbank Zurich Cantonalbank - Defense World
Does Biohaven Ltd. show high probability of reboundAI Powered Stock Trend Prediction Model - Newser
Investors in Biohaven Ltd. (BHVN): Protect Your RightsContact Levi & Korsinsky Before September 12, 2025 - ACCESS Newswire
BHVN INVESTORS: Kirby McInerney LLP Reminds Biohaven Ltd. - GlobeNewswire
ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Biohaven - GlobeNewswire
Pomerantz Law Firm Announces the Filing of a Class Action Against Biohaven Ltd. and Certain OfficersBHVN - PR Newswire
Biohaven Ltd. Sued for Securities Law Violations – - GlobeNewswire
Bragar Eagel & Squire, P.C. Urges Investors in XPLR - GlobeNewswire
Biohaven Ltd. Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky for More Information – BHVN - Morningstar
Biohaven Ltd. (BHVN) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - PR Newswire
Securities Lawsuit Alert: Biohaven Ltd. (BHVN) InvestorsContact Levi & Korsinsky Before September 12, 2025 - ACCESS Newswire
Biohaven Ltd. (NYSE:BHVN) Shares Sold by Universal Beteiligungs und Servicegesellschaft mbH - Defense World
BHVN Investors Have Opportunity To Lead Biohaven Ltd. Securities Fraud Lawsuit - Barchart.com
Biohaven Ltd. Investors: Please contact the Portnoy Law - GlobeNewswire
BHVN LAWSUIT ALERT: The Gross Law Firm Notifies Biohaven - GlobeNewswire
BHVN INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
Securities Class Action Lawsuit Filed Against Biohaven Ltd. (BHVN)Levi & Korsinsky Represents Shareholders - ACCESS Newswire
The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of September 12, 2025 in Biohaven Ltd. LawsuitBHVN - PR Newswire
What momentum shifts mean for Biohaven Ltd.Predictive System for Long-Term Stock Forecast - Newser
Is Biohaven Ltd. a good long term investmentAchieve triple-digit returns with smart investing - Jammu Links News
Lost Money on Biohaven Ltd. (BHVN)? Contact Levi & Korsinsky to Join Class Action Before September 12, 2025 - ACCESS Newswire
Published on: 2025-08-03 12:18:14 - Jammu Links News
SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Biohaven - GlobeNewswire
Pomerantz Law Firm Announces the Filing of a Class Action Against Biohaven Ltd. and Certain Officers – BHVN - FinancialContent
Shareholders that lost money on Biohaven Ltd.(BHVN) should contact Levi & Korsinsky about pending Class ActionBHVN - PR Newswire
Shareholders of Biohaven Ltd. Should Contact Levi & - GlobeNewswire
The Gross Law Firm Announces the Filing of a Securities Class Action on Behalf of Biohaven Ltd.(BHVN) Shareholders - PR Newswire
Lost Money on Biohaven Ltd. (BHVN)? Join Class Action Before September 12, 2025Contact Levi & Korsinsky - ACCESS Newswire
Investors in Biohaven Ltd. Should Contact The Gross Law - GlobeNewswire
Teradyne, Littelfuse, Marvell Technology, Cheesecake Factory And Other Big Stocks Moving Higher On Wednesday - Benzinga
바이오헤이븐 (BHVN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.24%
3.39%
자본화:
|
볼륨(24시간):